Michael T. Asbach, RPAC

Michael Asbach practices at Dent Neurologic Institute in Amherst, New York.

Michael Asbach's NPI, 1699030411, was assigned on July 9, 2012. Michael Asbach holds New York license 015665.

Michael Asbach's primary practice is Dent Neurologic Institute, at 3980 Sheridan Dr, Amherst, NY 14226-1727. The practice phone is (716) 250-2000.

Michael Asbach's primary practice is Dent Neurologic Institute in Amherst, New York. The medical group on file is DENT Neurologic Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Asbach practices. Vendor and product names are available with a free account.

Physician assistant is Michael Asbach's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michael Asbach is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Michael Asbach is licensed in New York.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression, drug use disorders, insomnia, intellectual and developmental disabilities and schizophrenia among the conditions Michael Asbach treats.

CMS data shows 761 Medicare services from Michael Asbach across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $21,156 for them. Every service was in an office.

CMS counts 131 Medicare patients who saw Michael Asbach in 2024. The largest group is under 65, with 87 patients. 73% of them have anxiety, and 71% have high cholesterol. 77% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Asbach's median patient age at 48, with 54% women.

In 2024, Michael Asbach wrote 6,074 Medicare Part D claims for 317 patients. 91% of them were for generic drugs. CMS names the drug for 5,876 of them, across 77 drugs with 11 or more claims each, at $1,346,935 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Michael Asbach for performance year 2024, reported as part of a group. Michael Asbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Asbach as offering telehealth.

CMS Open Payments shows 674 general payments to Michael Asbach from 24 drug and device companies in 2025. Speaker and faculty fees make up the largest share, 50% of the total. Axsome Therapeutics, Inc. paid the most, $71,766.